515
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Cancer Epidemiology

Changes in incidence trends of meningioma in Finland, 1990–2017: analysis of Finnish Cancer Registry data

, &
Pages 994-1000 | Received 15 Feb 2023, Accepted 14 Jul 2023, Published online: 05 Sep 2023

References

  • Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neuro Oncol. 2017;19(suppl_5):v1–v88. doi: 10.1093/neuonc/nox158.
  • Riemenschneider MJ, Perry A, Reifenberger G. Histological classification and molecular genetics of meningiomas. Lancet Neurol. 2006;5(12):1045–1054. doi: 10.1016/S1474-4422(06)70625-1.
  • Champeaux C, Weller J, Katsahian S. Epidemiology of meningiomas. A nationwide study of surgically treated tumours on French medico-administrative data. Cancer Epidemiol. 2019;58:63–70. doi: 10.1016/j.canep.2018.11.004.
  • Claus EB, Bondy ML, Schildkraut JM, et al. Epidemiology of intracranial meningioma. Neurosurgery. 2005;57(6):1088–1095. doi: 10.1227/01.neu.0000188281.91351.b9.
  • Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol. 2010;99(3):307–314. doi: 10.1007/s11060-010-0386-3.
  • Cea-Soriano L, Wallander M-A, García Rodríguez LA. Epidemiology of meningioma in the United Kingdom. Neuroepidemiology. 2012;39(1):27–34. doi: 10.1159/000338081.
  • Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231–1251. doi: 10.1093/neuonc/noab106.
  • Klaeboe L, Lonn S, Scheie D, et al. Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968–1997. Int J Cancer. 2005;117(6):996–1001. doi: 10.1002/ijc.21255.
  • Krampla W, Newrkla S, Pfisterer W, et al. Frequency and risk factors for meningioma in clinically healthy 75-year-old patients: results of the transdanube ageing study (VITA). Cancer. 2004;100(6):1208–1212. doi: 10.1002/cncr.20088.
  • Commins DL, Atkinson RD, Burnett ME. Review of meningioma histopathology. Neurosurg Focus. 2007;23(4):E3–E3. doi: 10.3171/FOC-07/10/E3.
  • Brenner AV, Sugiyama H, Preston DL, et al. Radiation risk of Central nervous system tumors in the life span study of atomic bomb survivors, 1958–2009. Eur J Epidemiol. 2020;35(6):591–600. doi: 10.1007/s10654-019-00599-y.
  • Ron E, Modan B, Boice JD, et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med. 1988;319(16):1033–1039. doi: 10.1056/NEJM198810203191601.
  • Smith MJ, Higgs JE, Bowers NL, et al. Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset. J Med Genet. 2011;48(4):261–265. doi: 10.1136/jmg.2010.085241.
  • Chan RC, Thompson GB. Morbidity, mortality, and quality of life following surgery for intracranial meningiomas: a retrospective study in 257 cases. J Neurosurg. 1984;60(1):52–60. doi: 10.3171/jns.1984.60.1.0052.
  • Kuratsu J-I, Kochi M, Ushio Y. Incidence and clinical features of asymptomatic meningiomas. J Neurosurg. 2000;92(5):766–770. doi: 10.3171/jns.2000.92.5.0766.
  • Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357(18):1821–1828. doi: 10.1056/NEJMoa070972.
  • Nakasu S, Hirano A, Shimura T, et al. Incidental meningiomas in autopsy study. Surg Neurol. 1987;27(4):319–322. doi: 10.1016/0090-3019(87)90005-x.
  • FCR. [cited 2019 Jul 31]. Available from: https://cancerregistry.fi/data-collection/cancer-information-notification/
  • Leinonen MK, Miettinen J, Heikkinen S, et al. Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours. Eur J Cancer. 2017;77:31–39. doi: 10.1016/j.ejca.2017.02.017.
  • Statistics Finland. 2019 [cited 2019 Jul 1]. Available from: http://pxnet2.stat.fi/PXWeb/pxweb/fi/StatFin/StatFin__vrm__vaerak/statfin_vaerak_pxt_11rb.px#_ga=2.175923874.1846213454.1562845248-49208598.1561978749
  • European Standard Population by Sex. 2019 [cited 2019 Jul 22]. Available from: https://www.opendata.nhs.scot/dataset/standard-populations/resource/29ce4cda-a831-40f4-af24-636196e05c1a
  • Kim H-J, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Statist. Med. 2000;19(3):335–351. doi: 10.1002/(SICI)1097-0258(20000215)19:3 < 335::AID-SIM336 > 3.0.CO;2-Z.
  • Joinpoint Regression Program. Version 4.9.1.0. Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute; 2022.
  • Achey RL, Gittleman H, Schroer J, et al. Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005–2015, using the Central brain tumor registry of the United States. Neuro Oncol. 2019;21(3):380–391. doi: 10.1093/neuonc/noy162.
  • Lin D, Lin J, Deng X, et al. Trends in intracranial meningioma incidence in the United States, 2004–2015. Cancer Med. 2019;8(14):6458–6467. doi: 10.1002/cam4.2516.
  • Bhala S, Stewart DR, Kennerley V, et al. Incidence of benign meningiomas in the United States: current and future trends. JNCI Cancer Spectr. 2021;5(3):pkab035. doi: 10.1093/jncics/pkab035.
  • Chebil C, Boumediene F, Cicero CE, et al. Incidence, survival and geoepidemiological analysis of meningiomas and glioblastomas in the province of Catania during the 2003–2016 period. Environ Res. 2021;200:111286. doi: 10.1016/j.envres.2021.111286.
  • Holleczek B, Zampella D, Urbschat S, et al. Incidence, mortality and outcome of meningiomas: a population-based study from Germany. Cancer Epidemiol. 2019;62:101562. doi: 10.1016/j.canep.2019.07.001.
  • Nilsson J, Järås J, Henriksson R, et al. No evidence for increased brain tumour incidence in the Swedish National Cancer Register between years 1980–2012. Anticancer Res. 2019;39(2):791–796. doi: 10.21873/anticanres.13176.
  • Ruonala V. Number of radiological examinations and procedures in Finland in 2021 (in Finnish with English summary) supervision report in health care. STUK-B 295. Vantaa; 2022.
  • Finnish Institute for Health and Welfare. Care Register for Health Care-THL; 2023 [cited 2023 Jun 1]. Available from: https://sampo.thl.fi/pivot/prod/fi/thil/perus01/fact_thil_perus01
  • Wang P-F, Ji W-J, Zhang X-H, et al. Allergy reduces the risk of meningioma: a meta-analysis. Sci Rep. 2017;7(1):40333. doi: 10.1038/srep40333.
  • Memon A, Rogers I, Paudyal P, et al. Dental X-rays and the risk of thyroid cancer and meningioma: a systematic review and meta-analysis of current epidemiological evidence. Thyroid. 2019;29(11):1572–1593. doi: 10.1089/thy.2019.0105.
  • Auvinen A, Cardis E, Blettner M, et al. Diagnostic radiological examinations and risk of intracranial tumours in adults—findings from the interphone study. Int J Epidemiol. 2022;51(2):537–546. doi: 10.1093/ije/dyab140.
  • Schlehofer B, Blettner M, Moissonnier M, et al. Association of allergic diseases and epilepsy with risk of glioma, meningioma and acoustic neuroma: results from the INTERPHONE international case–control study. Eur J Epidemiol. 2022;37(5):503–512. doi: 10.1007/s10654-022-00843-y.
  • Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry: experience in Finland. Acta Oncol. 1994;33(4):365–369. doi: 10.3109/02841869409098430.
  • Larjavaara S, Haapasalo H, Sankila R, et al. Is the incidence of meningiomas underestimated? A regional survey. Br J Cancer. 2008;99(1):182–184. doi: 10.1038/sj.bjc.6604438.
  • Christensen HC, Kosteljanetz M, Johansen C. Incidences of gliomas and meningiomas in Denmark, 1943 to 1997. Neurosurgery. 2003;52(6):1327–1334. doi: 10.1227/01.neu.0000064802.46759.53.
  • Larønningen S, Ferlay J, Beydogan H, et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries, Version 9.2. Association of the Nordic Cancer Registries. Cancer Registry of Norway; 2022 [cited 2023 May 31]. Available from: https://nordcan.iarc.fr/